Category & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 3
Medicine: Bavencio (avelumab)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 3
Medicine: Bavencio (avelumab)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 1
Medicine: Bavencio (avelumab), INLYTA®(AXITINIB)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 3
Medicine: Bavencio (avelumab), PF-05082566
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: brepocitinib (PF-06700841)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 2
Medicine: brepocitinib (PF-06700841)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 2
Medicine: brepocitinib (PF-06700841), ritlecitinib (PF-06651600)
PrintDownloadCategory & Conditions: Diabetes and Metabolic Disorders
Study Phase : 1
Medicine: danuglipron (PF-06882961)
PrintDownloadCategory & Conditions: Diabetes and Metabolic Disorders
Study Phase : 2
Medicine: danuglipron (PF-06882961)
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: Dekavil
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: Eucrisa (crisaborole)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 3/4
Medicine: Eucrisa (crisaborole)
PrintDownloadCategory & Conditions: Rare Diseases
Study Phase : 2
Medicine: fidanacogene elaparvovec (PF-06838435)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 3
Medicine: Ibrance (palbociclib)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 1/2
Medicine: Lorbrena (lorlatinib)
PrintDownloadCategory & Conditions: Rare Diseases
Study Phase : 2
Medicine: marstacimab (PF-06741086)
PrintDownload